Delivery Order SPE2DE24D0013-SPE2D626F13DK
- Not listed
- Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, was awarded a $6,800 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on January 9, 2026. This delivery order, designated XPRS4PLEX-10 with an ultimate completion date of January 16, 2026, is a child contract issued without a set-aside designation. The award represents procurement of diagnostic testing supplies and reagents under Cepheid's broader indefinite delivery contract...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $20,350 by the Defense Logistics Agency Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 20, 2026. This delivery order, designated as XPRS4PLEX-10, represents a child contract under Cepheid's larger Indefinite Delivery Contract vehicle with the Veterans Health Administration VISN 6, valued at $32.8 million and extending through September 30, 2030. The...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $7,480 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 14, 2026. This delivery order, valued at the ceiling amount, is issued under Cepheid's larger Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network 17, which is valued at $6.7...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $2,208 firm fixed-price delivery order (Contract No. XPRSTREPA-10) by the Medical Supply Chain, a Defense agency component, with a completion deadline of October 3, 2025. This delivery order was issued without a set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award falls under Cepheid's existing federal contracting relationship with defense...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $5,951.40 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of October 2, 2025. This firm fixed-price delivery order, issued on September 18, 2025, carries no set-aside designation and represents work to be performed at Cepheid's headquarters location in Sunnyvale, California. The delivery order is likely associated...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $2,723.58 by the Defense Department's Medical Supply Chain on August 5, 2025, with an ultimate completion date of August 12, 2025. The contract, which carries no set-aside designation, represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicles with the Department of Veterans Affairs. Cepheid specializes in advanced...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,720.00 by the Defense Logistics Agency Medical Supply Chain on January 9, 2026, with an ultimate completion date of January 16, 2026. This firm fixed-price delivery order, designated XPRS4PLEX-10, represents a child contract with no set-aside designation and is issued under Cepheid's broader Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network (VISN)...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $6,800 on January 7, 2026, by the Defense Logistics Agency Medical Supply Chain. This firm fixed-price delivery order, designated XPRS4PLEX-10, is scheduled for completion by January 14, 2026, and falls under Cepheid's existing Indefinite Delivery Contract with the Veterans Integrated Service Network 6 valued at $32.8M through September 30, 2030. No...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, has been awarded a delivery order valued at $2,040 under contract XPRS4PLEX-10 by the Medical Supply Chain, a defense-focused federal agency. This firm fixed-price delivery order, awarded on September 11, 2025, with an ultimate completion date of September 18, 2025, carries no set-aside designation. The work will be performed in Sunnyvale, California, and represents a continuation of Cepheid's ongoing...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order (XPRSMVP-10) valued at $2,304.20 under a Defense Logistics Agency Medical Supply Chain Indefinite Delivery Contract. This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 19, 2025, involves the supply of molecular diagnostic products, consistent with Cepheid's core business of providing advanced diagnostic solutions. The contract carries no set-aside...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F13DKDelivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $73,440 by the Defense Logistics Agency's Medical Supply Chain on January 16, 2026. This firm fixed-price delivery order, set to be completed by January 26, 2026, represents a child contract under a larger Indefinite Delivery Vehicle (IDV) with the Department of Veterans Affairs. The delivery order is expected to be performed at Cepheid's Sunnyvale location and involves the supply of diagnostic reagents and test kits, specifically XPRS4PLEX-10 cartridges designed for the GeneXpert diagnostic platform to support rapid molecular testing capabilities for multiple respiratory pathogens. This award reflects Cepheid's established role as a primary federal supplier of molecular diagnostic solutions across the VA healthcare system and other defense-affiliated medical agencies. The company holds substantial IDV contracts with the VA, including a $6.7M single-award vehicle with VISN 17 through December 2029 and a $32.8M single-award contract with VISN 6 extending through September 2030, both for diagnostic reagents and testing system assays. The current delivery order continues Cepheid's ongoing mission to provide critical diagnostic testing capabilities to support clinical laboratory operations and infectious disease detection across the federal healthcare network, with no small business set-aside designation applied.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $73.4k | 1/15/26 |